Skip to main content
. 2024 Feb 20;30(9):1984–1991. doi: 10.1158/1078-0432.CCR-23-1977

Figure 3.

Figure 3. Time-dependent Kaplan–Meier analysis based on DR comparing extended letrozole versus placebo in the overall BCI NSABP B-42 translational cohort for (A) all patients, (B) BCI (H/I)-Low, and (C) BCI (H/I)-High.

Time-dependent Kaplan–Meier analysis based on DR comparing extended letrozole versus placebo in the overall BCI NSABP B-42 translational cohort for (A) all patients, (B) BCI (H/I)-Low, and (C) BCI (H/I)-High.